The Microbiome Foundation is committed to improving the wellbeing and health of all through a better understanding of the role of the gut microbiota. Through initiatives to fund research on the microbiota and raise public awareness about how to preserve it – through diet, in particular – the Microbiome Foundation is supporting a scientific revolution and participating in a major paradigm shift in health.
Opening up new avenues for the wellbeing and health of all
2 PROJECTS TO BE FINANCED IN 2021
The gut microbiota: infinitely small, infinitely promising. A regulator of wellbeing
THE MICROBIOME FOUNDATION
Let’s stop making ourselves sick! The Microbiome Foundation – at the forefront of a health revolution
Because it’s about supporting a genuine scientific revolution. Research on the microbiota opens up new avenues for treating disorders for which there is currently no remedy.
WHY INFORM THE PUBLIC?
Maintaining our “health capital” depends above all on preserving our microbiota. Providing information empowers us all to become active participants in our health.
Two new research projects
In 2021, the Microbiome Foundation is supporting two major new projects in the field of gut microbiota:
The Autism and Microbiome project, an innovative and promising intestinal microbiota transplant therapy for autism spectrum disorders, which aims to restore the symbiosis between the host and its microbiota.
The French Gut project is part of the major international project called the Million Microbiome of Humans Project (MMHP) and aims to create the world’s largest human microbiota database, analyze 1 million samples and explore the full potential of the microbiome.
of the global population is overweight or obese – specifically, 1.9 billion adults, of which 650 million are obese
environmental factor: our modern diet
are overweight or obese
associated with obesity:
diabetes, NASH (fatty liver disease), cardiovascular events, cancer, depression...
die of these diseases every year
Associated public health costs:
$US 2 trillion per year
(1): Sources: OMS, McKinsey study
The Dassault Group is a longstanding founding partner of the Microbiome Foundation, supporting us since the launch of the PSC Fund. It was their strong commitment that allowed us to finance promising research on the link between disruption of the gut microbiota and primary sclerosing cholangitis, paving the way for new avenues of treatment. Also thanks to Dassault’s vital support, the Microbiome Foundation was able to get off the ground and is now evolving to support the scientific revolution represented by the gut microbiota.
As one of the very first French sponsors of scientific research, the Dassault Group has a long record of being involved.